Alasdair Breckenridge
Alasdair Breckenridge is a renowned British physician and pharmacologist, best known for his role as the chair of the Medicines and Healthcare products Regulatory Agency (MHRA). His contributions to the field of medicine, particularly in pharmacology and drug regulation, have been significant in shaping modern healthcare practices.
Early Life and Education[edit]
Alasdair Breckenridge was born in Scotland. He pursued his medical education at the University of St Andrews, where he developed a keen interest in pharmacology. He later completed his medical training at the University of Edinburgh, earning his medical degree.
Career[edit]
Breckenridge's career began in clinical medicine, but he soon transitioned to academia and research. He held various academic positions, including a professorship in clinical pharmacology at the University of Liverpool. His research focused on the pharmacokinetics and pharmacodynamics of drugs, contributing to a better understanding of how drugs interact with the human body.
Medicines and Healthcare products Regulatory Agency[edit]
In 2003, Breckenridge was appointed as the first chair of the Medicines and Healthcare products Regulatory Agency (MHRA), a position he held until 2012. Under his leadership, the MHRA became a leading authority in drug regulation, ensuring the safety and efficacy of medicines and medical devices in the UK. His tenure was marked by significant advancements in regulatory science and policy.
Contributions to Pharmacology[edit]
Breckenridge's work in pharmacology has been influential in the development of new drugs and therapies. He has published numerous research papers and has been involved in various clinical trials. His expertise in drug metabolism and safety has been recognized internationally.
Awards and Honors[edit]
Throughout his career, Breckenridge has received several awards and honors for his contributions to medicine and pharmacology. He has been a fellow of the Royal College of Physicians and has received honorary degrees from several universities.
Personal Life[edit]
Breckenridge is known for his dedication to public health and education. He has been involved in various initiatives to improve healthcare access and quality.
Also see[edit]
- Medicines and Healthcare products Regulatory Agency
- Pharmacology
- Drug regulation
- Clinical pharmacology
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
